Optiver Holding
PCRX icon

Optiver Holding’s Pacira BioSciences PCRX Stock Holding History

Optiver Holding’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.67K Buy
184
+164
+820% +$3.88K ﹤0.01% 2013
2026
Q1 		$452 Sell
20
-50
-71% -$1.11K ﹤0.01% 2174
2025
Q4 		$1.81K Sell
70
-148
-68% -$3.52K ﹤0.01% 2062
2025
Q3 		$5.62K Buy
+218
New +$5.35K ﹤0.01% 1647

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optiver Holding's PCRX Position: Q2 2026 in Review

Optiver Holding increased its Pacira BioSciences (PCRX) stake by 820% in Q2 2026, buying an estimated $3.88K and bringing the position to 184 shares worth $4.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2013.

Optiver Holding first reported a position in PCRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.62K in Q3 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Optiver Holding held 184 shares of Pacira BioSciences worth $4.67K as of Q2 2026.
  • Optiver Holding bought 164 Pacira BioSciences shares in Q2 2026, an estimated $3.88K.
  • Pacira BioSciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2013 holding.
  • Optiver Holding first reported a position in Pacira BioSciences in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Pacira BioSciences position peaked at $5.62K in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.